Gene Writing Technology Market Report 2026

Gene Writing Technology Market Overview

• Gene Writing Technology market size has reached to $5.62 billion in 2025 • Expected to grow to $16.97 billion in 2030 at a compound annual growth rate (CAGR) of 24.8% • Growth Driver: Growth In Gene Therapy Development Driving The Market Growth Due To Advancements In Genetic Engineering And Regulatory Support • Market Trend: Next-Generation Solutions Driving Precision Therapies For Rare And Common Genetic Diseases • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gene Writing Technology Market?

Gene writing technology refers to a set of advanced biotechnological methods used to design, synthesize, and precisely assemble DNA sequences, enabling scientists to create, modify, or insert genes with high accuracy. This technology focuses on building new genetic sequences from scratch or rewriting long stretches of DNA, supporting applications in synthetic biology, medicine, agriculture, and biotechnology. The main technologies of gene writing technology include chemical deoxyribonucleic acid synthesis and enzymatic deoxyribonucleic acid synthesis. Chemical deoxyribonucleic acid (DNA) synthesis refers to the laboratory process of artificially creating DNA sequences from nucleotides without using living cells. The various product types include Gene Editing tools, gene synthesis platforms, delivery systems, and others. The different applications involved are therapeutics, research, agriculture, and diagnostics, and they are used by several end users such as pharmaceutical and biotechnology companies, academic and research institutes, hospitals and clinics, and other end users.

What Is The Gene Writing Technology Market Growth Forecast?

The gene writing technology market size is expected to see exponential growth in the next few years. It will grow to $16.97 billion in 2030 at a compound annual growth rate (CAGR) of 24.8%. The growth in the forecast period can be attributed to growing development of gene-based therapeutics, increasing automation in DNA synthesis platforms, rising investment in agricultural biotechnology innovation, expanding use of AI-driven gene design tools, increasing demand for scalable and cost-efficient DNA manufacturing. Major trends in the forecast period include increasing adoption of enzymatic DNA synthesis methods, growing demand for long-sequence DNA assembly, rising investment in synthetic biology platforms, expansion of custom gene design services, growing integration of automated gene synthesis workflows.

Global Gene Writing Technology Market Segmentation

1) By Technology: Chemical Deoxyribonucleic Acid Synthesis, Enzymatic Deoxyribonucleic Acid Synthesis 2) By Product Type: Gene Editing Tools, Gene Synthesis Platforms, Delivery Systems, Other Product Types 3) By Application: Therapeutics, Research, Agriculture, Diagnostics 4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals And Clinics, Other End Users Subsegments: 1) By Chemical Deoxyribonucleic Acid Synthesis: Solid Phase Synthesis, Liquid Phase Synthesis, Microarray Based Synthesis, Chip Based Synthesis 2) By Enzymatic Deoxyribonucleic Acid Synthesis: Polymerase Mediated Synthesis, Ligase Mediated Synthesis, Recombinase Mediated Synthesis, Template Independent Synthesis

What Is The Driver Of The Gene Writing Technology Market?

The growth in gene therapy development is expected to propel the growth of the gene writing technology market going forward. Gene therapy development refers to the increasing research, clinical trials, and regulatory approvals of therapies that treat or correct genetic diseases by altering genes. Gene therapy development is rising due to rapid advancements in genetic engineering technologies and supportive regulatory frameworks that enable more therapies to progress from research to clinical trials and approvals. Gene writing technology supports gene therapy development by providing precise, efficient, and programmable tools to edit, insert, or correct specific genes, enabling the creation of safer and more effective therapies for a wide range of genetic disorders. For instance, in January 2024, according to the American Society of Gene & Cell Therapy, a US-based organization for gene and cell therapy, in fourth quarter (Q4) 2023, the number of gene therapies in Phase III increased by 10% from the previous quarter, marking the first rise since third quarter (Q3) 2022. Therefore, the growth in gene therapy development is driving the growth of the gene writing technology industry.

Key Players In The Global Gene Writing Technology Market

Major companies operating in the gene writing technology market are Beam Therapeutics Inc., Twist Bioscience Corporation, Sangamo Therapeutics Inc., Editas Medicine Inc., Tessera Therapeutics Inc., Precision BioSciences Inc., Metagenomi Inc., Mammoth Biosciences Inc., Synbio Technologies Inc., Arbor Biotechnologies Inc., Intellia Therapeutics Inc., Inscripta Inc., Edigene Inc., Recombinetics Inc., Pairwise Plants Inc., Caribou Biosciences Inc., GenEdit Inc., BRL Medicine Inc., Eligo Bioscience Inc., Prime Medicine Inc., ToolGen Inc., iECURE Inc., Cellectis S.A.

Global Gene Writing Technology Market Trends and Insights

Major companies operating in the gene writing technology market are focusing on developing innovative solutions such as in vivo gene editing therapy to precisely correct disease-causing genes and provide durable treatments for genetic disorders. In vivo gene editing therapy is a treatment that directly modifies a patient’s genes inside their body to correct disease-causing mutations, helping to provide precise, long-lasting solutions for genetic disorders without the need for repeated treatments. For instance, in January 2026, Tessera Therapeutics Inc., a US-based biotechnology company, announced the advancement of TSRA-196, an in vivo gene writing–based therapy targeting alpha-1 antitrypsin deficiency (AATD). TSRA-196 is designed for intravenous administration using the company’s proprietary lipid nanoparticle delivery system to deliver RNA to liver cells. Built on a target-primed reverse transcription (TPRT) platform, the therapy is intended to permanently correct the underlying SERPINA1 gene mutation, with the potential to restore functional AAT protein expression. This approach aims to overcome the limitations of conventional augmentation therapies, which provide only temporary symptomatic relief.

What Are Latest Mergers And Acquisitions In The Gene Writing Technology Market?

In February 2024, Intellia Therapeutics Inc., a US-based clinical-stage gene editing company that specializes in providing gene writing technology, partnered with ReCode Therapeutics Inc. to develop novel gene editing therapies for cystic fibrosis (CF). With this partnership, Intellia Therapeutics, Inc. and ReCode Therapeutics, Inc. aim to combine Intellia’s CRISPR-based DNA editing technology with ReCode’s Selective Organ Targeting (SORT) lipid nanoparticle delivery platform to precisely correct CF-causing gene mutations, improve treatment options for patients with limited therapies, and accelerate development of next-generation gene editing therapeutics. ReCode Therapeutics Inc. is a US-based company specializing in targeted delivery of genetic medicines using LNP technology for rare and common diseases.

Regional Insights

North America was the largest region in the gene writing technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gene Writing Technology Market?

The gene writing technology market consists of revenues earned by entities by providing services such as designing, synthesizing, and editing genetic sequences, developing customized gene constructs, delivering genome engineering solutions, and offering consulting or support for precise genetic modifications. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene writing technology market consists of sales of gene synthesis platforms, genome editing tools, gene writing software, related reagents and kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Gene Writing Technology Market Report 2026?

The gene writing technology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gene writing technology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.